| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 698493
[patent_doc_number] => 07067279
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-06-27
[patent_title] => 'Cell culture performance with betaine'
[patent_app_type] => utility
[patent_app_number] => 10/226931
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4591
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067279.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226931
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226931 | Cell culture performance with betaine | Aug 22, 2002 | Issued |
Array
(
[id] => 729117
[patent_doc_number] => 07041789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-09
[patent_title] => 'RFRP-3 and DNA thereof'
[patent_app_type] => utility
[patent_app_number] => 10/487634
[patent_app_country] => US
[patent_app_date] => 2002-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 48673
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/041/07041789.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487634
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487634 | RFRP-3 and DNA thereof | Aug 21, 2002 | Issued |
Array
(
[id] => 1009527
[patent_doc_number] => 06900289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-31
[patent_title] => 'Physalia fluorescent proteins'
[patent_app_type] => utility
[patent_app_number] => 10/226877
[patent_app_country] => US
[patent_app_date] => 2002-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 25
[patent_no_of_words] => 36871
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/900/06900289.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226877
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226877 | Physalia fluorescent proteins | Aug 21, 2002 | Issued |
Array
(
[id] => 6913186
[patent_doc_number] => 20050176944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Intracellular signaling molecules'
[patent_app_type] => utility
[patent_app_number] => 10/487092
[patent_app_country] => US
[patent_app_date] => 2002-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74587
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176944.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487092
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487092 | Intracellular signaling molecules | Aug 15, 2002 | Abandoned |
Array
(
[id] => 6657104
[patent_doc_number] => 20030077820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Novel human collagen proteins and polynucleotides encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/219449
[patent_app_country] => US
[patent_app_date] => 2002-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9796
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077820.pdf
[firstpage_image] =>[orig_patent_app_number] => 10219449
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/219449 | Novel human collagen proteins and polynucleotides encoding the same | Aug 13, 2002 | Abandoned |
Array
(
[id] => 6843583
[patent_doc_number] => 20030148930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Human zona pellucida proteins and methods of their use in diagnoising male infertility'
[patent_app_type] => new
[patent_app_number] => 10/209664
[patent_app_country] => US
[patent_app_date] => 2002-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23979
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148930.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209664
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209664 | Human zona pellucida proteins and methods of their use in diagnosing male infertility | Jul 31, 2002 | Issued |
Array
(
[id] => 6804953
[patent_doc_number] => 20030232347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Therapeutic polypeptides, nucleic acids encoding same, and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/211689
[patent_app_country] => US
[patent_app_date] => 2002-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69383
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232347.pdf
[firstpage_image] =>[orig_patent_app_number] => 10211689
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/211689 | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | Jul 31, 2002 | Issued |
Array
(
[id] => 418671
[patent_doc_number] => 07276342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-02
[patent_title] => 'Xobesin agonists and antagonists for the treatment of metabolic disorders'
[patent_app_type] => utility
[patent_app_number] => 10/485233
[patent_app_country] => US
[patent_app_date] => 2002-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11851
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/276/07276342.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485233
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485233 | Xobesin agonists and antagonists for the treatment of metabolic disorders | Jul 30, 2002 | Issued |
Array
(
[id] => 7275689
[patent_doc_number] => 20040235140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Expression system'
[patent_app_type] => new
[patent_app_number] => 10/483150
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3357
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10483150
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/483150 | Expression system | Jul 8, 2002 | Issued |
Array
(
[id] => 7365267
[patent_doc_number] => 20040005690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Modified CBD/RGD recombinant attachment factor for improving cell-attachment efficiency and the manufacturing method thereof'
[patent_app_type] => new
[patent_app_number] => 10/180120
[patent_app_country] => US
[patent_app_date] => 2002-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3496
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005690.pdf
[firstpage_image] =>[orig_patent_app_number] => 10180120
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/180120 | Modified CBD/RGD recombinant attachment factor for improving cell-attachment efficiency and the manufacturing method thereof | Jun 26, 2002 | Abandoned |
| 10/070787 | METHOD FOR INCREASING THE YIELD OF RECOMBINANT PROTEINS IN MICROBIAL FERMENTATION PROCESSES | Jun 17, 2002 | Abandoned |
Array
(
[id] => 737999
[patent_doc_number] => 07034132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-25
[patent_title] => 'Therapeutic polypeptides, nucleic acids encoding same, and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/162335
[patent_app_country] => US
[patent_app_date] => 2002-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96627
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/034/07034132.pdf
[firstpage_image] =>[orig_patent_app_number] => 10162335
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/162335 | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | Jun 2, 2002 | Issued |
| 10/148713 | Novel polypeptide---human lipoprotein 105 containing cytochrome c structural domain and polynucleotide encoding it | May 27, 2002 | Abandoned |
Array
(
[id] => 7440191
[patent_doc_number] => 20040185428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Lectin protein prepared from korean marine crab philyra pisum, process for preparing the same and the use thereof'
[patent_app_type] => new
[patent_app_number] => 10/476904
[patent_app_country] => US
[patent_app_date] => 2004-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4981
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20040185428.pdf
[firstpage_image] =>[orig_patent_app_number] => 10476904
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/476904 | Lectin protein prepared from Korean marine crab Philyra pisum, process for preparing the same and the use thereof | May 3, 2002 | Issued |
Array
(
[id] => 923115
[patent_doc_number] => 07319087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-15
[patent_title] => 'Antimicrobial polypeptide from Aspergillus niger'
[patent_app_type] => utility
[patent_app_number] => 10/474647
[patent_app_country] => US
[patent_app_date] => 2002-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 13083
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/319/07319087.pdf
[firstpage_image] =>[orig_patent_app_number] => 10474647
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/474647 | Antimicrobial polypeptide from Aspergillus niger | May 2, 2002 | Issued |
Array
(
[id] => 6725499
[patent_doc_number] => 20030207811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Method of treating retinopathy of prematurity using somatostatin analogs'
[patent_app_type] => new
[patent_app_number] => 10/138554
[patent_app_country] => US
[patent_app_date] => 2002-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6587
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207811.pdf
[firstpage_image] =>[orig_patent_app_number] => 10138554
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/138554 | Method of treating retinopathy of prematurity using somatostatin analogs | May 2, 2002 | Abandoned |
Array
(
[id] => 978826
[patent_doc_number] => 06929929
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-16
[patent_title] => 'Method for the expression of proteins in in vitro translation systems with coexpression of folding helper proteins'
[patent_app_type] => utility
[patent_app_number] => 10/133534
[patent_app_country] => US
[patent_app_date] => 2002-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5959
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/929/06929929.pdf
[firstpage_image] =>[orig_patent_app_number] => 10133534
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/133534 | Method for the expression of proteins in in vitro translation systems with coexpression of folding helper proteins | Apr 25, 2002 | Issued |
Array
(
[id] => 651089
[patent_doc_number] => 07112666
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-26
[patent_title] => 'Von Willebrand Factor (Vwf)-cleaving protease'
[patent_app_type] => utility
[patent_app_number] => 10/475538
[patent_app_country] => US
[patent_app_date] => 2002-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 27
[patent_no_of_words] => 15619
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/112/07112666.pdf
[firstpage_image] =>[orig_patent_app_number] => 10475538
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/475538 | Von Willebrand Factor (Vwf)-cleaving protease | Apr 24, 2002 | Issued |
Array
(
[id] => 7206084
[patent_doc_number] => 20050043227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Use of hypoxia inducible factor 2alpha for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension'
[patent_app_type] => utility
[patent_app_number] => 10/475403
[patent_app_country] => US
[patent_app_date] => 2002-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19666
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043227.pdf
[firstpage_image] =>[orig_patent_app_number] => 10475403
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/475403 | Use of hypoxia inducible factor 2alpha for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension | Apr 23, 2002 | Abandoned |
Array
(
[id] => 7405627
[patent_doc_number] => 20040175778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Method for increasing productivity of secondary metabolite by conferring drug-resistant mutations'
[patent_app_type] => new
[patent_app_number] => 10/473364
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7166
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20040175778.pdf
[firstpage_image] =>[orig_patent_app_number] => 10473364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/473364 | Method for increasing productivity of secondary metabolite by conferring drug-resistant mutations | Mar 28, 2002 | Issued |